IRCT2017081635382N4
Recruiting
Phase 2
Evaluation of the Effect of autologous blood transfusion on the treatment of De Quervain's tenosynovitis
Vice Chancellor for research of Iran University of Medical Sciences0 sites30 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- De Quervain's.
- Sponsor
- Vice Chancellor for research of Iran University of Medical Sciences
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of De Quervain's disease; age of 18 to 60 years; no history of rheumatic disorder such as rheumatoid arthritis; no history of depression and other mental disorders; no history of previous intervention for the treatment of De Quervain's disease.
- •Exclusion criteria: loss of follow\-up.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
The impact of cell salvage on blood transfusion rates in major hepatobiliary surgeryColorectal liver metastasesIMPN pancreasHCCSurgery - Other surgeryBlood - AnaemiaCancer - Biliary tree (gall bladder and bile duct)Cancer - LiverCancer - PancreaticACTRN12623000161628Mr Alex Gordon-Weeks501
Recruiting
Phase 3
The effect of autologous blood on plantar fasciitisIRCT20160508027797N7Babol University of Medical Sciences90
Recruiting
N/A
Effect of Blood Transfusion in Covid-19Respiratory status of patients with Covid 19.COVID-19, virus identifiedU07.1IRCT20201003048904N1Boushehr University of Medical Sciences40
Recruiting
N/A
Clinical Study of autologous blood injection for the treatment of recurrent temporomandibular joint dislocatioJPRN-UMIN000022197Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Oral and Maxillofacial Surgery20
Withdrawn
N/A
Clinical Study of the Use of an Autologous Blood Filtration Device in the Treatment of Critical Limb IschemiaNL-OMON48317William Cook Europe ApS50